Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pembrolizumab + Chemotherapy in Advanced Thymoma/Thymic Carcinoma
NCT04554524Phase 4Unknown
- Sponsor
- Tangdu Hospital
- Start
- Aug 2020
- Primary completion
- Jul 2024
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of pembrolizumab in thymoma, thymic carcinoma (TC), sponsored by Tangdu Hospital. Status: unknown.
02
Drugs
03
Conditions
thymomathymic carcinoma (TC)
Beyond the preview
Go deeper on NCT04554524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04554524.